Teva's Generic Evista Approved In The U.S.
Teva announced that its generic equivalent to Evista 60 mg tablets has been approved in the U.S. The approval makes Teva's generic version eligible for 180 days of marketing exclusivity.
Wed Mar 05, 2014
Teva Announces Approval of Generic Evista Tablets
Mar. 4, 2014-- Teva Pharmaceutical Industries Ltd. announces the approval of the generic equivalent to Evista Tablets, 60 mg, in the United States.
Teva gets FDA approval for generic osteoporosis drug
The Food and Drug Administration approved Teva Pharmaceutical Industries' application to market a generic version of the osteoporosis drug Evista.
Wed Feb 26, 2014
Osteoporosis Drug Being Used To Fight Certain Cancers
Evista, which was developed and is marketed by drug industry giant Eli Lilly and Co., has shown potential as a treatment for certain cancers, such as breast cancer and liver cancer.
Fri Feb 21, 2014
Eli Lilly's Osteoporosis Drug Raloxifene May Also Treat Cancers
Researchers from the Oregon State University found that Raloxifene, used in the treatment of osteoporosis in post-menopausal women, may also be effective against some types of liver and breast cancers.
Tue Feb 18, 2014
Osteoporosis drug may treat breast and liver cancers, OSU study finds
Oregon State University's Siva Kolluri, who led research into osteoporosis drugs and their application as possible treatments for some kinds of breast cancer and liver cancer.
Mon Feb 17, 2014
Oregon State University researchers find osteoporosis drug might work against breast and liver cancers
A drug that lots of post-menopausal women take to prevent and treat osteoporosis keeps making news and the latest comes from Oregon State University researchers.